Clinical Trial Update: Nedaplatin in Treatment for Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for nedaplatin in treating nasopharyngeal carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Nedaplatin (nedaplatin)

Snippet

Sponsor: Affiliated Cancer Hospital & Institute of Guangzhou Medical University | Conditions: Nasopharyngeal Carcinoma | Phase 2 | Status: COMPLETED